SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'E3M'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.51A | 1a4gA-6br6A:54.5 | 1a4gA-6br6A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.14A | 1a4gA-6br6A:54.5 | 1a4gA-6br6A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.50A | 1a4gB-6br6A:54.5 | 1a4gB-6br6A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ILE A 222 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.3A) | 0.16A | 1a4gB-6br6A:54.4 | 1a4gB-6br6A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.49A | 1l7fA-6br6A:64.7 | 1l7fA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | E3M A 511 (-3.0A)E3M A 511 (-3.8A)E3M A 511 (-2.9A) | 0.17A | 1l7fA-6br6A:undetectable | 1l7fA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.49A | 1l7gA-6br6A:64.7 | 1l7gA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 0.53A | 1l7hA-6br6A:64.6 | 1l7hA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | E3M A 511 (-3.0A)E3M A 511 (-3.8A)E3M A 511 (-2.9A) | 0.17A | 1l7hA-6br6A:64.6 | 1l7hA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.25A | 1nncA-6br6A:64.3 | 1nncA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 156TRP A 178ILE A 222 | E3M A 511 (-2.9A)NoneNoneE3M A 511 ( 4.3A) | 0.18A | 1nncA-6br6A:64.3 | 1nncA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.30A | 2cmlA-6br6A:64.6 | 2cmlA-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.19A | 2cmlA-6br6A:64.6 | 2cmlA-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.27A | 2cmlB-6br6A:64.6 | 2cmlB-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.23A | 2cmlB-6br6A:64.6 | 2cmlB-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.31A | 2cmlC-6br6A:64.6 | 2cmlC-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.29A | 2cmlC-6br6A:64.6 | 2cmlC-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.29A | 2cmlD-6br6A:64.5 | 2cmlD-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.24A | 2cmlD-6br6A:64.5 | 2cmlD-6br6A:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.36A | 2f0zA-6br6A:2.7 | 2f0zA-6br6A:12.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156GLU A 277ARG A 292ARG A 371TYR A 406 | NoneE3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 1.05A | 2f0zA-6br6A:2.7 | 2f0zA-6br6A:12.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.38A | 2f10A-6br6A:8.4 | 2f10A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 152ARG A 156GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)NoneE3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.51A | 2htqA-6br6A:63.2 | 2htqA-6br6A:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTQ_A_ZMRA472_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151TRP A 178ILE A 222ARG A 224 | E3M A 511 (-2.9A)NoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A) | 0.38A | 2htqA-6br6A:63.2 | 2htqA-6br6A:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ILE A 222ARG A 224GLU A 276ARG A 292TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.0A)E3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 (-2.3A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.49A | 2htuA-6br6A:64.0 | 2htuA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 118ASP A 151GLU A 227ARG A 371 | E3M A 511 (-3.0A)E3M A 511 (-2.9A)E3M A 511 ( 4.8A)E3M A 511 (-2.9A) | 0.47A | 2htuA-6br6A:64.0 | 2htuA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.33A | 3b7eA-6br6A:64.4 | 3b7eA-6br6A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.10A | 3b7eA-6br6A:64.4 | 3b7eA-6br6A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.31A | 3b7eB-6br6A:64.4 | 3b7eB-6br6A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.10A | 3b7eB-6br6A:64.4 | 3b7eB-6br6A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 152GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.40A | 3ckzA-6br6A:64.2 | 3ckzA-6br6A:14.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 6 | ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224 | E3M A 511 (-2.9A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A) | 0.71A | 3ckzA-6br6A:64.2 | 3ckzA-6br6A:14.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneNoneNoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.50A | 3k37A-6br6A:54.6 | 3k37A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ARG A 371 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-2.9A) | 0.39A | 3k37A-6br6A:54.6 | 3k37A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneNoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A) | 0.45A | 3k37B-6br6A:54.4 | 3k37B-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152GLU A 276TYR A 406 | E3M A 511 (-3.8A)E3M A 511 (-2.3A)E3M A 511 (-4.5A) | 0.26A | 3k37B-6br6A:54.4 | 3k37B-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.61A | 3k39A-6br6A:53.9 | 3k39A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.57A | 3k39B-6br6A:54.0 | 3k39B-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.64A | 3k39C-6br6A:53.9 | 3k39C-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.45A | 3k39C-6br6A:53.9 | 3k39C-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A) | 0.65A | 3k39D-6br6A:53.9 | 3k39D-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.60A | 3k39E-6br6A:54.0 | 3k39E-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.59A | 3k39F-6br6A:53.8 | 3k39F-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.60A | 3k39G-6br6A:54.0 | 3k39G-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.60A | 3k39H-6br6A:27.2 | 3k39H-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.64A | 3k39I-6br6A:53.9 | 3k39I-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.44A | 3k39I-6br6A:53.9 | 3k39I-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.65A | 3k39J-6br6A:53.8 | 3k39J-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.46A | 3k39J-6br6A:53.8 | 3k39J-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.64A | 3k39K-6br6A:53.9 | 3k39K-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.45A | 3k39K-6br6A:53.9 | 3k39K-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.64A | 3k39L-6br6A:53.9 | 3k39L-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.46A | 3k39L-6br6A:53.9 | 3k39L-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.60A | 3k39M-6br6A:53.9 | 3k39M-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.60A | 3k39N-6br6A:53.9 | 3k39N-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.62A | 3k39O-6br6A:53.9 | 3k39O-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.61A | 3k39P-6br6A:54.0 | 3k39P-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.26A | 3sanA-6br6A:65.2 | 3sanA-6br6A:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.19A | 3sanA-6br6A:65.2 | 3sanA-6br6A:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.26A | 3sanB-6br6A:65.1 | 3sanB-6br6A:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.19A | 3sanB-6br6A:65.1 | 3sanB-6br6A:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.29A | 3ti5A-6br6A:64.5 | 3ti5A-6br6A:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.11A | 3ti5A-6br6A:64.5 | 3ti5A-6br6A:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.29A | 3ti5B-6br6A:64.5 | 3ti5B-6br6A:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.11A | 3ti5B-6br6A:64.5 | 3ti5B-6br6A:13.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151TRP A 178GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)NoneE3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.27A | 3ticA-6br6A:74.5 | 3ticA-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156ILE A 222ARG A 224 | NoneE3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A) | 0.13A | 3ticA-6br6A:74.5 | 3ticA-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.27A | 3ticB-6br6A:74.6 | 3ticB-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.09A | 3ticB-6br6A:74.6 | 3ticB-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.28A | 3ticC-6br6A:74.6 | 3ticC-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.10A | 3ticC-6br6A:74.6 | 3ticC-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.27A | 3ticD-6br6A:74.6 | 3ticD-6br6A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.10A | 3ticD-6br6A:74.6 | 3ticD-6br6A:90.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UM5_A_CP6A609_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | ILE A 257PHE A 205THR A 225SER A 179ILE A 194 | NoneNoneNoneE3M A 511 ( 4.0A)None | 1.07A | 3um5A-6br6A:undetectable | 3um5A-6br6A:8.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UM5_B_CP6B709_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | ILE A 257PHE A 205THR A 225SER A 179ILE A 194 | NoneNoneNoneE3M A 511 ( 4.0A)None | 1.07A | 3um5B-6br6A:undetectable | 3um5B-6br6A:8.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.33A | 4b7nA-6br6A:64.3 | 4b7nA-6br6A:11.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.11A | 4b7nA-6br6A:64.3 | 4b7nA-6br6A:11.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.33A | 4b7qA-6br6A:64.1 | 4b7qA-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | E3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A) | 0.28A | 4b7qA-6br6A:64.1 | 4b7qA-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.39A | 4b7qB-6br6A:64.1 | 4b7qB-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneE3M A 511 (-3.8A)NoneNone | 0.15A | 4b7qB-6br6A:64.1 | 4b7qB-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.35A | 4b7qC-6br6A:64.0 | 4b7qC-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | E3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A) | 0.17A | 4b7qC-6br6A:64.0 | 4b7qC-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.37A | 4b7qD-6br6A:64.2 | 4b7qD-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.26A | 4b7qD-6br6A:64.2 | 4b7qD-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.56A | 4cpnA-6br6A:54.6 | 4cpnA-6br6A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.49A | 4cpnA-6br6A:54.6 | 4cpnA-6br6A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.10A | 4cpnA-6br6A:54.6 | 4cpnA-6br6A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.45A | 4cpnB-6br6A:54.6 | 4cpnB-6br6A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.49A | 4cpnB-6br6A:54.6 | 4cpnB-6br6A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.55A | 4cpzA-6br6A:54.4 | 4cpzA-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.45A | 4cpzA-6br6A:54.4 | 4cpzA-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178 | NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNone | 0.23A | 4cpzA-6br6A:54.1 | 4cpzA-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.49A | 4cpzB-6br6A:14.4 | 4cpzB-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNone | 0.28A | 4cpzB-6br6A:14.5 | 4cpzB-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.53A | 4cpzC-6br6A:54.2 | 4cpzC-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.49A | 4cpzC-6br6A:54.2 | 4cpzC-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.23A | 4cpzC-6br6A:54.2 | 4cpzC-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.50A | 4cpzD-6br6A:54.2 | 4cpzD-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.47A | 4cpzD-6br6A:54.2 | 4cpzD-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNone | 0.23A | 4cpzD-6br6A:54.2 | 4cpzD-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.57A | 4cpzE-6br6A:54.2 | 4cpzE-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.48A | 4cpzE-6br6A:54.2 | 4cpzE-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.18A | 4cpzE-6br6A:54.2 | 4cpzE-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.55A | 4cpzF-6br6A:54.1 | 4cpzF-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.17A | 4cpzF-6br6A:54.1 | 4cpzF-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.54A | 4cpzG-6br6A:54.1 | 4cpzG-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.19A | 4cpzG-6br6A:54.1 | 4cpzG-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.59A | 4cpzH-6br6A:54.2 | 4cpzH-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 1.48A | 4cpzH-6br6A:54.2 | 4cpzH-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | E3M A 511 (-3.8A)NoneNone | 0.22A | 4cpzH-6br6A:54.1 | 4cpzH-6br6A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.44A | 4i00A-6br6A:65.7 | 4i00A-6br6A:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 156TRP A 178ILE A 222ASN A 294 | NoneNoneNoneE3M A 511 ( 4.3A)E3M A 511 ( 3.1A) | 0.88A | 4i00A-6br6A:65.7 | 4i00A-6br6A:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.19A | 4mwrA-6br6A:64.6 | 4mwrA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152TRP A 178ILE A 222 | NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A) | 0.22A | 4mwrA-6br6A:64.6 | 4mwrA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152ILE A 222ARG A 224GLU A 227 | E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A) | 1.29A | 4mwvA-6br6A:64.6 | 4mwvA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.46A | 4mwvA-6br6A:64.6 | 4mwvA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118GLU A 227ARG A 371 | E3M A 511 (-3.0A)E3M A 511 ( 4.8A)E3M A 511 (-2.9A) | 0.20A | 4mwvA-6br6A:64.6 | 4mwvA-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.26A | 4mwxA-6br6A:64.6 | 4mwxA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A) | 0.11A | 4mwxA-6br6A:64.6 | 4mwxA-6br6A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | E3M A 511 (-3.6A)NoneE3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.0A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-4.5A) | 0.45A | 4mx0A-6br6A:64.4 | 4mx0A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ASP A 151ARG A 371 | E3M A 511 (-3.0A)E3M A 511 (-2.9A)E3M A 511 (-2.9A) | 0.33A | 4mx0A-6br6A:64.4 | 4mx0A-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.44A | 4wa5A-6br6A:63.4 | 4wa5A-6br6A:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A)E3M A 511 (-3.8A) | 0.52A | 4wa5A-6br6A:63.4 | 4wa5A-6br6A:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.29A | 5l17A-6br6A:64.7 | 5l17A-6br6A:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152TRP A 178ILE A 222 | NoneE3M A 511 (-3.8A)NoneE3M A 511 ( 4.3A) | 0.16A | 5l17A-6br6A:64.7 | 5l17A-6br6A:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MQT_A_STIA302_1 (DEOXYCYTIDINE KINASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | VAL A 398GLU A 277PHE A 422SER A 279GLU A 375 | NoneE3M A 511 ( 3.6A)NoneNoneNone | 1.45A | 5mqtA-6br6A:undetectable | 5mqtA-6br6A:13.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.29A | 6ekuA-6br6A:21.0 | 6ekuA-6br6A:7.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276ARG A 292ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 (-2.9A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.26A | 6hcxA-6br6A:12.2 | 6hcxA-6br6A:46.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
6br6 | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | TRP A 178ILE A 222GLU A 277 | NoneE3M A 511 ( 4.3A)E3M A 511 ( 3.6A) | 0.14A | 6hcxA-6br6A:12.2 | 6hcxA-6br6A:46.25 |